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ABSTrAcT
The present study was undertaken to determine the effects of erythromycin on urinary bladder muscle 
contractions in hyperthyroid rats. Totally 12 rats were assigned into 2 groups (6 rats in each group), as the 
control and hyperthyroid rat groups. The contractile responses were determined as Emax and pD2 of carbachol 
(10-3-10-8 M) and potassium (1-6×10-2
 
M, KCl) in the absence and presence of erythromycin (10-3; 5×10-4; 10-4 
M). The contractile responses to carbachol (10-3-10-8 M) in the presence of verapamil (10-8 M), atropine (10-
8 M), or in calcium-free Krebs solution were also determined in the absence and presence of erythromycin 
(10-3 M). Treatment of erythromycin significantly reduced the response to carbachol and KCl-evoked 
contractions. Carbachol-evoked contractions were reduced in the presence of atropine, whereas the atropine-
resistant components of carbachol-evoked contractions were not inhibited in the presence of erythromycin. The 
contractile response to carbachol was reduced in calcium-free Krebs solution and 10-8 M verapamil. In addition, 
when erythromycin was added together with verapamil 10-8 M, the contractile response to carbachol was 
inhibited. In conclusion, erythromycin more effectively inhibited urinary bladder contractions in hyperthyroid 
rats than the control rats, through calcium movement inhibition.
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Introduction 
Thyroid hormones have an important role in the organism in terms of their effects on 
metabolism, development, thermoregulation, and growth (LAZAR, 1993). In addition to 
these, various pathological conditions, such as Graves’ disease and tumors of the thyroid, 
produce more hormones, which results in hyperthyroidism (GULCELIK et al., 2006). 
Increases in the level of these hormones cause not only basal metabolic disorders but 
also health problems, such as diabetes mellitus and cardiovascular diseases (PANDA and 
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KAR, 2007). Hyperthyroidism may also cause dysfunctions of the lower urinary tract (HO 
et al., 2011) and distressing symptoms such as nocturia, which is a source of significant 
problems for many patients (WEIN et al., 2002).
The effects of erythromycin, as an antibiotic and prokinetic agent, on smooth muscle 
contractions have been evaluated comprehensively in many studies (ARMSTRONG et 
al., 1992; MINOCHA and GALLIGAN, 1991; NISSAN et al., 1997; TAMAOKI et al., 1995). 
In an experiment with healthy volunteers, dose-dependent erythromycin acts through 
two different mechanisms: intravenous erythromycin (200 mg) evoked non-propagating, 
atropine-resistant contractions of the stomach by direct action on the muscle, whereas 
a lower dose (40 mg) stimulated propagating gastric motility, prevented by atropine 
(COULIE et al., 1998). In mammals, through experiments with isolated rabbit stomachs, low 
concentrations of motilin and erythromycin greatly facilitated cholinergically mediated 
contractions evoked by electrical field stimulation (EFS), whereas higher concentrations 
contracted the muscle (DASS et al., 2003; JARVIE et al., 2007).
FURNESS et al. (1999) reported that erythromycin lactobionate caused the 
concentration-dependent inhibition of nerve-mediated contractions on the longitudinal 
muscle of guinea-pig ileum. In this study, erythromycin inhibited the contractile responses 
of the guinea-pig ileum induced by EFS and carbachol. At the same time, erythromycin 
has no action on the motilin receptor of the ileum. Also, NISSAN et al. (2002) suggested that 
erythromycin antagonized, in a concentration-dependent manner, the direct cholinergic 
effects on various smooth muscles in the human alimentary tract. DEPOORTERE and 
PEETERS (1997) characterized the inhibitory effect of erythromycin as mediated through 
calcium channels, and this effect was not mediated by motilin receptors. ENGLAND et al. 
(2004) reported that it inhibited the contractile responses of EFS, carbachol, and potassium, 
but did not notably reduce direct detrusor muscle contractions in rats. Furthermore, EFS-
evoked contractions were inhibited by atropine and erythromycin. Erythromycin, together 
with nifedipine, reduced carbachol responses in a calcium-free Krebs solution. Our study 
was aimed at determining the effects of erythromycin on the contractile response of 
isolated hyperthyroid rats’ urinary bladders, and to investigate whether erythromycin has 
more effect on the hyperthyroid rats than the control rats.
Materials and methods
Chemicals. Carbachol, atropine, verapamil, ethylene glycol tetraacetic acid (EGTA), 
potassium chloride (KCl) and L-thyroxine obtained from Sigma-Aldrich (Sigma-Aldrich 
Chemical Co., St. Louis, MO, USA) were used as trial compounds. All the other chemicals 
and reagents were purchased from commercial suppliers. 
animals and tissue preparation. Twelve adult male Wistar rats (obtained from the 
Experimental Animal Research and Application Center, Afyonkarahisar, Turkey) of 
approximately the same age and weighing 180-220 g, were used for the study. The animals 
were divided into 2 groups as follows; the first group, the control group (n = 6), was fed a 
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normal rat diet and not treated by any procedure. The second group, the hyperthyroidism 
group (n = 6), was induced by subcutaneous L-thyroxin (ARAGÃO et al., 2007) at a dose 
of 50 µg/100g/day for 10 days.
At the end of the experiment, blood samples from each group were collected and 
transferred into non-heparinised tubes. Serum levels of free and total T3 and T4 hormones 
were analyzed by colorimetric enzyme immunoassay, using individual ELISA kits (DRG 
International, USA). Then the animals were sacrificed by cervical dislocation and the 
abdominal cavities were opened. After that the urinary bladders of the rats were removed 





1.2 mM, MgCl2 2.5 mM, glucose 11 mM, CaCl2 2.5 mM, in distilled water 
pH 7.2, aerated with 95% O2, 5% CO2 and warmed to 37 ºC). Each urinary bladder was 
flushed with buffer and mounted in 20 mL organ baths, filled with gassed Krebs solution, 
and maintained at 37 ºC. The bladders were placed in an organ bath and one end of the 
bladder muscle was anchored to a stationary clamp and the other end attached to an 
isometric force transducer (The BioPac system and MP35 acquisition box were used with 
FDT05 finger transducers). The chambers were prefilled with 15 mL Krebs solution at 
37 ºC and constantly bubbled with 95% O2 and 5% CO2. The bladder muscle was placed 
under tension of 0.5 g for 1 hour to equilibrate. Further, the bladder muscles were placed 
in Krebs solution for 20 minutes’ recovery time between the different concentration-
response curves.
The pD2 is defined as the negative logarithm of the EC50. The potency of a drug is 
generally quantified as the EC50. This designates the concentration of agonist required 
to provoke a response halfway between the baseline and the maximum response (Emax) 
of a dose-response curve. The value of the highest contractile response (maximal 
contraction) was taken as 100%, and the percentages of the other contractile responses 
of the concentrations were calculated. With these calculations, pD2 and Emax values were 
obtained using “GraphPad Prism version 5 for Windows”. Evaluation of the obtained 
responses was performed by comparing the effects of erythromycin on the pD2 and Emax 
values of carbachol and KCl.
Erythromycin was dissolved in 0.25% ethanol (ENGLAND et al., 2004). Erythromycin, 
atropine, carbachol, verapamil, and KCl were prepared in either normal Krebs or 
calcium-free Krebs solution on the day of the experiment. Calcium-free Krebs solution 
was prepared without CaCl2 and with the addition of EGTA 10-5
 
M [12]. The experimental 
protocols were approved by the Animal Care and Use Committee at Afyon Kocatepe 
University (Ethical number: 2013/263).
experimental protocol. the effect of erythromycin on carbachol-evoked responses. 
The control dose response curves of carbachol were obtained and then repeated in the 
presence of 10-3, 5×10-4 and 10-4 M erythromycin. 10-3-10-8 M carbachol cumulative 
concentrations were used in the experiments. In these experiments, the effects of 
erythromycin were determined on the direct contractile response of rat urinary bladders.
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the effect of atropine on carbachol-evoked responses in the absence and presence 
of erythromycin. Control carbachol dose response curves (10-3-10-8M) were obtained and 
then repeated after incubation with erythromycin 10-3 M for 10 minutes each. Further 
responses were obtained after incubation with 10-8 M atropine alone and then with 10-8 M 
atropine plus 10-3 M erythromycin. 
the effect of erythromycin on potassium-evoked responses. To determine the effect 
of erythromycin on the contractile response to potassium, a control contractile response 




M and then repeated after the bladders were 
treated with erythromycin (10-3; 5×10-4; 10-4 M) in an organ bath including Krebs solution 
for 10 minutes.
the effect of verapamil on carbachol-evoked responses in the absence and presence 
of erythromycin. The effect of erythromycin on the contractile response to carbachol 
was determined in the presence of erythromycin and verapamil. Contractile responses 
of control were obtained from carbachol (10-3-10-8 M) and then repeated after incubation 
with Krebs and 10-8 M verapamil alone, or with 10-8 M verapamil plus erythromycin 10-3 
M.
the effects of erythromycin and verapamil on carbachol-evoked responses in normal 
and calcium-free krebs solution. To determine the effect of erythromycin on intracellular 
calcium release, carbachol-evoked contractile responses were determined in calcium-free 
Krebs solution. Control contractile responses to carbachol (10-3-10-8
 
M) were determined 
in normal Krebs solution and then in Ca2+
 
free Krebs solution. The evoked responses 
to carbachol in calcium-free Krebs solution were obtained following the disappearance 
of spontaneous contractions after the Krebs solution was changed from that containing 
calcium to calcium-free. The bladders were then reincubated with normal Krebs solution 
for 10 minutes to permit the intracellular calcium stores to be replenished. The normal 
Krebs solution was then switched to calcium-free Krebs solution and the samples were 
incubated with either 10-8
 
M verapamil alone or with 10-8
 
M verapamil plus erythromycin 
10-3 M, before being stimulated once more with 10-3-10-8
 
M carbachol, when the 
spontaneous contractions had ceased. 
statistical analyses. Statistical calculations and graphs were done with “GraphPad 
Prism version 5 for Windows” (GRAPHPAD, 2010). The results are presented as mean ± 
SD. Statistical analyses were carried out using one-way analysis of variance followed 
by Bonferroni’s correction for multiple comparisons. Also, comparisons of control and 
hyperthyroid groups were analyzed with the student t-test. Differences were considered 
significant when the P value was <0.05.
results
serum t3 and t4 analyses. Free and total T3 and T4 levels are shown in Table 1. In our 
study, the values of these parameters were found to be higher in the hyperthyroid group 
compared to the control (P<0.001).
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the effect of erythromycin on carbachol-evoked responses. Erythromycin 10-3 M 
(P<0.001) and 5×10-4 M (P<0.01) reduced the Emax responses of the bladders to carbachol 
in the control group (Table 2). In addition, erythromycin 10-3 M, 5×10-4 M and 10-4 M 
(P<0.001) reduced the Emax responses of the bladders to carbachol in the hyperthyroid 
group (Table 2). Carbachol Emax responses in the presence of 5×10-4 M and 10-4 M 
erythromycin were found to be lower in the hyperthyroid group compared to the control 
(P<0.001). Also, erythromycin did not have any effect on pD2 responses of the bladders to 
carbachol in either group. The dose-response curve of carbachol alone or in the presence 
of erythromycin is also shown in Fig. 1A and B.
Fig. 1. The concentration-contraction relationships of carbachol treatment (10-3-10-8 M) alone 
and with erythromycin (10-3; 5×10-4; 10-4 M) in control (A) and hyperthyroid rats (B). After 
observing the control responses to carbachol (10-3-10-8 M), the urinary bladders were treated with 
erythromycin (10-3; 5×10-4; 10-4 M) for 10 min. Carbachol was applied in the presence of the 
drug, and the contractile responses to carbachol were compared with the responses in the control. 
Ordinate: the amplitude of the contraction was expressed as mg of carbachol (10-3-10-8 M)-
induced contraction. Abscissa: the concentration of drugs (log M). Each point represents the mean 
of six experiments with SD shown by a vertical line.
A
B
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Table 1. Free (F) T3 and T4 or Total (T) T3 and T4 levels in serum samples of control and 
hyperthyroid rats
Groups (n:6) FT3 (pg/dL) FT4 (ng/dL) TT3 (ng/dL) TT4 (µg/dL)
Control 29.9 ± 5.1 0.5 ± 0.1 26.7 ± 4.0 4.2 ± 0.7
Hyperthyroid 56.4 ± 7.4*** 1.2 ± 0.1*** 128.9 ± 3.2*** 6.9 ± 1.2***
Values in the same column marked with stars show statistically significant differences ***P<0.001. Data are 
expressed as the means ± SD.
Table 2. The Emax and pD2 responses of carbachol and carbachol plus 10-3, 5×10-4, and 10-4 M 
erythromycin on urinary bladders in control and hyperthyroid rats
Treatment (n:6) Control Hyperthyroid P value
Carbachol cumulative
Emax 101.6 ± 3.4 103.5 ± 6.1 0.501
pD2 5.2 ± 1.3 5.7 ± 0.8 0.843
Erythromycin 10-3 M + 
Carbachol cumulative
Emax 66.6 ± 9.2*** 62.4 ± 7.2*** 0.408
pD2 4.8 ± 0.4 3.6 ± 1.6 0.830
Erythromycin 5×10-4 M + 
Carbachol cumulative
Emax 86.5 ± 7.4** 60.4 ± 7.4*** 0.000
pD2 4.7 ± 0.8 4.0 ± 1.3 0.269
Erythromycin 10-4 M + 
Carbachol cumulative
Emax 99.5 ± 1.3 77.9 ± 8.6*** 0.000
pD2 5.0 ± 1.5 4.8 ± 0.8 0.016
In the same row values with P value and in the same column values with stars show statistically significant 
differences **P<0.01; ***P<0.001. In the presence of erythromycin, carbachol Emax and pD2 levels were 
compared with carbachol cumulative levels. Data are expressed as the means ± SD.
Table 3. The Emax and pD2 responses of carbachol and carbachol plus 10-3 M erythromycin or 10-8 
M atropine on urinary bladders in rats
Treatment (n:6) Control Hyperthyroid P value
Carbachol cumulative
Emax 101.5 ± 3.4 103.5 ± 6.1 0.501
pD2 5.7 ± 1.0 5.2 ± 1.2 0.477
Atropine 10-8 M + 
Carbachol cumulative
Emax 87.9 ± 4.9*** 83.3 ± 3.3*** 0.088
pD2 4.8 ± 0.4 4.5 ± 1.4 0.713
Erythromycin 10-3 M 
+ Atropine 10-8 M + 
Carbachol cumulative
Emax 86.5 ± 3.8*** 84.1 ± 4.1*** 0.314
pD2 4.7 ± 0.4 4.5 ± 0.4 0.238
In the same row values with P value and in the same column values with stars show statistically significant 
differences ***P<0.001. In the presence of atropine and atropine plus erythromycin, carbachol Emax and pD2 
levels were compared with carbachol cumulative levels. Data are expressed as the means ± SD.
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the effect of atropine on carbachol-evoked responses in the absence and presence of 
erythromycin. Incubation of bladders with 10-8 M atropine and 10-8 M atropine plus 10-3 
M erythromycin reduced the carbachol Emax compared to carbachol Emax alone (P<0.001). 
Additionally, 10-8 M atropine plus 10-3 M erythromycin did not show any significant 
difference in carbachol Emax compared to carbachol Emax in the presence of 10-8 M atropine 
(Table 3). 10-8 M atropine alone and the 10-8 M atropine plus 10-3 M erythromycin 
treatment reduced carbachol responses as shown in Fig. 2A and B. Erythromycin had no 
significant effect on the pD2 responses of rat bladders to carbachol in either group.
Fig. 2. The concentration-contraction relationships of carbachol treatment (10-3-10-8 M) alone or 
with erythromycin (10-3 M) and atropine (10-8 M) in control (A) and hyperthyroid rats (B). After 
observing the control responses to carbachol (10-3-10-8 M), the urinary bladders were treated 
with erythromycin (10-3; 5×10-4; 10-4 M) or atropine (10-8 M) for 10 min. Carbachol was applied 
in the presence of these drugs and the contractile responses to carbachol were compared with 
the responses in the control. Ordinate: the amplitude of the contraction was expressed as mg of 
carbachol (10-3-10-8 M)-induced contraction. Abscissa: the concentration of drugs (log M). Each 
point represents the mean of six experiments with SD shown by a vertical line.
A
B
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Fig. 3. The concentration-contraction relationships of potassium chloride treatment (KCl; 1-6×10-2 
M) alone and with erythromycin (10-3; 5×10-4; 10-4 M) in control (A) and hyperthyroid rats (B). 
After observing the control responses to KCl (1-6×10-2 M), the urinary bladders were treated 
with erythromycin (10-3; 5×10-4; 10-4 M) for 10 min. KCl was applied in the presence of the drug 
and the contractile responses to KCl were compared with the responses in the control. Ordinate: 
the amplitude of the contraction was expressed as mg of KCl (1-6×10-2 M)-induced contraction. 
Abscissa: the concentration of drugs (log M). Each point represents the mean of six experiments 
with SD shown by a vertical line.
A
B
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Table 4. The Emax and pD2 responses of 1×10-6 - 6×10-6 M KCl and KCl plus 10-3, 5×10-4, and 10-4 
M erythromycin on urinary bladders in rats
Treatment (n:6) Control Hyperthyroid P value
KCl cumulative
Emax 99.1 ± 4.1 94.8 ± 4.3 0.104
pD2 2.1 ± 0.2 2.1 ± 0.4 0.283
Erythromycin 10-3 M  
+ KCl cumulative
Emax 90.4 ± 1.8** 85.2 ± 2.7*** 0.003
pD2 1.8 ± 0.2 1.8 ± 0.3 0.126
Erythromycin 5×10-4 M 
+ KCl cumulative
Emax 91.3 ± 3.1** 86.7 ± 2.9** 0.029
pD2 1.8 ± 0.5 1.8 ± 1.0 0.122
Erythromycin 10-4 M 
 + KCl cumulative
Emax 93.4 ± 4.2 89.6 ± 2.9 0.094
pD2 1.8 ± 1.0 1.9 ± 0.2 0.808
In the same row values with P value and in the same column values with stars show statistically significant 
differences **P<0.01; ***P<0.001. In the presence of erythromycin, KCl Emax and pD2 levels were compared 
with carbachol cumulative levels. Data are expressed as the means ± SD.
Table 5. The Emax and pD2 responses of carbachol and carbachol plus 10-3 M erythromycin and 10-8 
M verapamil on rat urinary bladder in normal and calcium-free Krebs solution
Treatment (n:6) Control Hyperthyroid P value
Carbachol cumulative
Emax 101.5 ± 3.4 103.5 ± 6.1 0.501
pD2 4.8 ± 0.4 4.8 ± 0.8 0.843
Verapamil 10-8 M + 
Carbachol cumulative
Emax 89.9 ± 2.1*** 89.3 ± 2.7*** 0.355
pD2 4.3 ± 0.7 4.2 ± 0.5 0.371
Erythromycin 10-3 M 
+ Verapamil 10-8 M + 
Carbachol cumulative
Emax 82.6 ± 2.3*** 84.3 ± 2.6*** 0.086
pD2 3.9 ± 0.6 3.9 ± 0.5 0.135
Carbachol cumulative in 
Calcium-free Krebs
Emax 92.2 ± 3.1** 93.6 ± 2.7*** 0.435
pD2 3.5 ± 0.5* 3.5 ± 0.5** 0.467
Verapamil 10-8 M + 
Carbachol cumulative in 
Calcium-free Krebs
Emax 80.0 ± 4.1*** 84.1 ± 3.7*** 0.280
pD2 3.1 ± 0.6*** 3.1 ± 0.5*** 0.587
Erythromycin 10-3 M 
+ Verapamil 10-8 M + 
Carbachol cumulative in 
Calcium-free Krebs
Emax 71.2 ± 6.6*** 73.4 ± 3.2*** 0.016
pD2 2.8 ± 0.6*** 2.6 ± 0.2*** 0.835
In the same row values with P value and in the same column values with stars show statistically significant 
differences *P<0.05; **P<0.01; ***P<0.001. In the presence of verapamil or Ca-free verapamil alone and 
together with erythromycin, carbachol Emax and pD2 levels were compared with carbachol cumulative levels. 
Data are expressed as the means ± SD.
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the effect of erythromycin on potassium-evoked responses. 10-3 M and 5×10-4 M 
erythromycin (P<0.01) reduced the Emax responses of bladders to KCl in the control group 
(Table 4). Similarly, 10-3 M (P<0.001) and 5×10-4 M (P<0.01) erythromycin reduced the 
Emax responses of bladders to KCl in the hyperthyroid group (Table 4). KCl Emax responses 
in the presence of 5×10-4 M and 10-4 M erythromycin were found to be lower in the 
hyperthyroid group compared with the control (P<0.05). The dose-response curves of 
KCl alone or in the presence of erythromycin are shown in Fig. 3A and B. Erythromycin 
had no significant effect on the pD2 responses of rat bladders to KCl in either group.
the effect of verapamil on carbachol-evoked responses in the absence and presence 
of erythromycin. To determine the effect of erythromycin on calcium release from 
intracellular stores, responses to carbachol were obtained in the presence of verapamil, 
a potent inhibitor of Ca2+ influx through L-type (REUTER, 1983; INCE and FILAZI, 
2009). The addition of 10-8 M verapamil to the organ bath reduced the Emax compared 
to carbachol control responses (P<0.001) in the control and hyperthyroid groups. The 
further addition of erythromycin 10-3 M reduced Emax compared to the carbachol control 
responses (P<0.001) in the control and hyperthyroid groups (Table 5). The effects of 
10-8 M verapamil and 10-3 M erythromycin treatment on carbachol responses are shown 
in Fig. 4A and B. Erythromycin had no significant effect on the pD2 responses of rats’ 
bladders to carbachol in either group.
the effect of erythromycin and verapamil on carbachol-evoked responses in calcium-
free krebs solution. The experiment described above was repeated in calcium-free Krebs 
solution to further assess the effect of erythromycin on intracellular calcium stores. 
A lower concentration of 10-8 M verapamil was used to reduce the possibility of non-
specific effects, with a shorter incubation period (until spontaneous contractions ceased) 
to minimize the loss of calcium from intracellular stores. The contractile responses of 
bladders to carbachol in calcium-free Krebs solution inhibited the Emax of the control 
(P<0.01) and hyperthyroid (P<0.001) groups, and the pD2 of the control (P<0.05) and 
hyperthyroid (P<0.01) groups, compared to the control responses in normal Krebs 
solution. Addition of 10-8 M verapamil to calcium-free Krebs solution had an additional 
inhibitory effect on the Emax and pD2 responses to carbachol. When erythromycin 10-3 M 
was added with 10-8 M verapamil it inhibited carbachol Emax and pD2 responses compared 
to calcium-free+10-8 M verapamil-carbachol responses (Table 5), and the groups’ 
responses are shown in Fig. 4A and B.
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Discussion
The present study showed that erythromycin had a more potent ability to inhibit 
carbachol and KCl contractions in hyperthyroid rats than in control rats. Carbachol is a 
cholinomimetic agent and has an important role in smooth muscle contraction (MOKRY et 
al., 2002). In this study, erythromycin (10-3; 5×10-4; 10-4 M) treatment affected the Emax of 
carbachol in the hyperthyroid rats. This suggests that the urinary bladder of hyperthyroid 
rats has a more sensitive response and erythromycin could be more potent in hyperthyroid 
Fig. 4. The concentration-contraction relationships of carbachol treatment (10-3-10-8 M) alone 
or with erythromycin (10-3 M) and verapamil (10-8 M) in normal and Ca-free Krebs solutions of 
control (A) and hyperthyroid rats (B). After observing the control responses to carbachol (10-3-10-8 
M), the urinary bladders were treated with verapamil (10-8 M) or Ca-free verapamil (10-8 M) alone 
and together with erythromycin (10-3 M) for 10 min. Carbachol was applied in the presence of 
these drugs and the contractile responses to carbachol were compared with the responses in the 
control. Ordinate: the amplitude of the contraction was expressed as mg of carbachol (10-3-10-8 
M)-induced contraction. Abscissa: the concentration of drugs (log M). Each point represents the 
mean of six experiments with SD shown by a vertical line.
A
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rats. Pretreatment with 10-8 M atropine attenuated carbachol contractions in both groups. 
However, 10-3 M erythromycin treatment did not change the atropine-resistant response to 
carbachol, indicating that erythromycin may not affect the muscarinic receptors binding 
carbachol in the urinary bladder. 
KCl may depolarize the cellular membrane and activate the calcium channel, resulting 
in calcium inflow and then smooth muscle contraction (VAN et al., 1980). Erythromycin 
inhibited KCl response and it was concluded that the effect of erythromycin on the urinary 
bladder is related to Ca2+, and affects the Ca2+ pathway. Also, erythromycin (10-3 and 





M) in the urinary bladders of hyperthyroid rats more than in normal rats, due 
to the failing function of the urinary bladder.
Verapamil is an L-type calcium channel antagonist, and inhibits smooth muscle 
contractions by inhibiting Ca2+ influx via the calcium channel. Correspondingly, 
erythromycin acts as a Ca2+ channel antagonist and inhibited the extracellular Ca2+ influx 
through the calcium channel (ENGLAND et al., 2004). Similarly, in our study, a sub-maximal 
verapamil dose reduced carbachol Emax levels in the urinary bladder. 10-3 M erythromycin 
and verapamil treatment slightly reduced Emax levels of carbachol obtained with verapamil 
in the urinary bladders of all the rats. As is known, Ca2+ has an important role in smooth 
muscle contraction. Ca2+ concentration is increased in the cytoplasm, causing smooth 
muscle contraction. This comes from sarcoplasmic reticulum (SR) release or influx, via 
different Ca2+ channels. Also, Ca2+ is mainly stored in the SR of smooth muscle cells. In 
addition, extracellular Ca2+ influx is a good way of maintaining continuous smooth muscle 
contractions and restoring the Ca2+ pool (KONG et al., 2006). To investigate the possible 
effects, we investiged the 10-3 M erythromycin carbachol-evoked contractile responses 
of urinary bladders on normal and hyperthyroid rats perfused with calcium free Krebs 
solution including verapamil, to remove the calcium entry component. Contractions were 
reduced in the absence of extracellular calcium, and inhibited further by the calcium 
entry blocker, verapamil, indicating residual contractile activity in these experiments. 
The addition of 10-3 M erythromycin to calcium free and verapamil-containing Krebs 
solution inhibited the Emax and pD2 levels of carbachol, suggesting inhibitory activity on 
the release of intracellular calcium or alteration of the calcium contractile mechanism 
within the cells. This suggested that erythromycin correspondingly inhibited both the 
release of intracellular calcium and extracellular Ca2+ influx in normal and hyperthyroid 
rats, and similarly to studies undertaken by other researchers (NISSAN et al., 1999; 
ENGLAND et al., 2004), it reduced muscle contractions by calcium influx-efflux. Also, 
erythromycin affected the urinary bladder contractions of hyperthyroid rats more due to 
bladder dysfunction.
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To date, the pharmacological effects of erythromycin have been demonstrated by 
many studies (ARMSTRONG et al., 1992; MINOCHA and GALLIGAN, 1991; NISSAN et 
al., 1997; TAMAOKI et al., 1995; NISSAN et al., 1999; PEETERS et al., 1989), for example 
on erythromycin inhibited ileum contractions in guinea pigs (NISSAN et al., 1999), and 
smooth muscle gallbladder contractions in guinea pigs (NISSAN et al., 1997) and humans 
(TAMAOKI et al., 1995). However, erythromycin increased motility in the terminal rabbit 
ileum by the activation of dihydropyridine-sensitive calcium channels (ARMSTRONG et 
al., 1992). Also, DEPOORTERE and PEETERS (1997) reported that erythromycin reduced 
gastrointestinal smooth muscle contractions in rabbits, and this inhibitory effect of 
erythromycin was mediated by means of calcium channels, thereby reducing calcium 
influx. 
In conclusion, the results show that erythromycin has an effect on urinary bladder 
contractions induced by carbachol or KCl and also their contractile effects are more 
affected by erythromycin in hyperthyroid rats than in normal rats. For these reasons, 
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KArAcA, A., S. IncE: Eritromicin oslabljuje kontraktilne odgovore na izoliranom 
mokraćnom mjehuru hipertireotičnih štakora. Vet. arhiv 86, 825-839, 2016.
Sažetak
Istraženi su učinci eritromicina na kontrakcije mišića mokraćnog mjehura u hipertireotičnih štakora. 
Dvanaest štakora bilo je svrstano u dvije skupine, kontrolnu i pokusnu (po šest štakora u svakoj skupini). 
Kontraktilni odgovor izražen kao Emax i pD2 na karbakol (10-3-10-8 M) i kalij (1-6×10-2 M, KCl) bili su određeni 
u odsutnosti i prisutnosti eritromicina (10-3; 5×10-4; 10-4 M). Kontraktilni odgovori na karbakol (10-3-10-8 
M) u prisutnosti verapamila (10-8 M), atropina (10-8 M), ili u Krebsovoj otopini bez kalcija, bili su također 
određivani u odsutnosti i prisutnosti eritromicina (10-3 M). Primjena eritromicina značajno je smanjila odgovor 
na kontrakciju potaknutu karbakolom i kalijevim kloridom. Kontrakcije potaknute karbakolom bile su smanjene 
u prisutnosti atropina, dok komponente kontrakcija izazvane karbakolom rezistentne na atropin nisu bile 
inhibirane u prisutnosti eritromicina. Kontraktilni odgovor na karbakol bio je smanjen u Krebsovoj otopini 
bez kalcija i 10-8 M otopini verapamila. Povrh toga, kontraktilni odgovor na karbakol bio je inhibiran kad je 
eritromicin bio primijenjen zajedno s 10-8 M verapamilom. Može se zaključiti da je eritromicin učinkovitije 
inhibirao kontrakcije mokraćnog mjehura hipertireotičnih štakora nego u kontrolnih štakora putem inhibicije 
kolanja kalcija. 
ključne riječi: eritromicin, hipertireoidizam, mokraćni mjehur, kontrakcija, inhibicija, štakor ________________________________________________________________________________________
.
